Physician profile
Jennifer Lim
NPI 1528288990
$991.37
in general payments reported to CMS, 2019-2025
8 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $52.78 · 2023: $345 · 2024: $211 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $362.09 | 2023-2025 | Invega Sustenna, Spravato |
| Lilly USA, LLC | $247.87 | 2022-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $102.47 | 2023-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $82.43 | 2023-2025 | |
| Novo Nordisk INC | $75.33 | 2024-2025 | Wegovy, Saxenda |
| Glaxosmithkline, LLC. | $68.67 | 2022-2023 | Arexvy, Shingrix |
| Amgen INC. | $28.91 | 2025 | Otezla, Repatha |
| Pfizer INC. | $23.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.